H. G. Dammann

1.0k total citations
70 papers, 678 citations indexed

About

H. G. Dammann is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. G. Dammann has authored 70 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 37 papers in Gastroenterology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. G. Dammann's work include Helicobacter pylori-related gastroenterology studies (45 papers), Gastroesophageal reflux and treatments (28 papers) and Gastrointestinal motility and disorders (10 papers). H. G. Dammann is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (45 papers), Gastroesophageal reflux and treatments (28 papers) and Gastrointestinal motility and disorders (10 papers). H. G. Dammann collaborates with scholars based in Germany, Austria and Italy. H. G. Dammann's co-authors include Bernd Simon, Peter Müller, P.P. Keohane, M. Dreyer, Peter Müller, W Fuchs, W Londong, R. Kangah, Götz M. Richter and Michel Cremer and has published in prestigious journals such as The Lancet, Gastroenterology and Gut.

In The Last Decade

H. G. Dammann

62 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. G. Dammann Germany 16 461 351 135 100 81 70 678
C. J. Gavey United Kingdom 10 295 0.6× 216 0.6× 114 0.8× 53 0.5× 28 0.3× 13 424
Lisa Suchower United States 12 403 0.9× 187 0.5× 145 1.1× 74 0.7× 86 1.1× 19 613
Markus Goldschmiedt United States 11 266 0.6× 153 0.4× 98 0.7× 37 0.4× 66 0.8× 20 417
T. Cilluffo Switzerland 9 259 0.6× 272 0.8× 71 0.5× 58 0.6× 19 0.2× 14 450
J. Zimmerman Israel 17 382 0.8× 204 0.6× 37 0.3× 57 0.6× 69 0.9× 33 741
L. Carling Sweden 15 821 1.8× 648 1.8× 139 1.0× 27 0.3× 165 2.0× 35 977
V. Londong Germany 8 187 0.4× 146 0.4× 60 0.4× 56 0.6× 19 0.2× 11 321
Madeline H. Frame United Kingdom 12 407 0.9× 348 1.0× 327 2.4× 37 0.4× 59 0.7× 19 825
I. G. M. Cleator Canada 10 337 0.7× 117 0.3× 66 0.5× 55 0.6× 23 0.3× 32 538
E Thornell Sweden 14 215 0.5× 61 0.2× 165 1.2× 41 0.4× 83 1.0× 22 414

Countries citing papers authored by H. G. Dammann

Since Specialization
Citations

This map shows the geographic impact of H. G. Dammann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. G. Dammann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. G. Dammann more than expected).

Fields of papers citing papers by H. G. Dammann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. G. Dammann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. G. Dammann. The network helps show where H. G. Dammann may publish in the future.

Co-authorship network of co-authors of H. G. Dammann

This figure shows the co-authorship network connecting the top 25 collaborators of H. G. Dammann. A scholar is included among the top collaborators of H. G. Dammann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. G. Dammann. H. G. Dammann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dreyer, M., et al.. (2008). Senkung der Plasma-Lipidkonzentration durch Lovastatin: Ergebnisse einer klinischen Prüfung bei Patienten mit primärer Hypercholesterinämie. DMW - Deutsche Medizinische Wochenschrift. 114(45). 1734–1739.
2.
Schulz, H.‐U., et al.. (2004). Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine a double-blind study in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 42(9). 481–487. 12 indexed citations
3.
Dammann, H. G., et al.. (1999). Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.. PubMed. 11(11). 1277–82. 44 indexed citations
4.
Dammann, H. G., et al.. (1997). Lansoprazole versus omeprazole: influence on meal‐stimulated gastric acid secretion. Alimentary Pharmacology & Therapeutics. 11(2). 359–364. 40 indexed citations
5.
Dammann, H. G., et al.. (1994). Effects of pantoprazole on endocrine function in healthy male volunteers. Alimentary Pharmacology & Therapeutics. 8(5). 549–554. 13 indexed citations
6.
Dammann, H. G., et al.. (1993). Differential effects of misoprostol and ranitidine on the pharmacokinetics of diclofenac and gastrointestinal symptoms. British Journal of Clinical Pharmacology. 36(4). 345–349. 8 indexed citations
7.
Londong, W, H. Barth, H. G. Dammann, et al.. (1991). Dose‐related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Alimentary Pharmacology & Therapeutics. 5(3). 245–254. 47 indexed citations
8.
Dammann, H. G., et al.. (1990). Gastric Aspiration Technique for pH Recording: A Critical Evaluation of This Method. Digestive Diseases. 8(1). 3–9. 12 indexed citations
9.
Dammann, H. G., M. Dreyer, Peter Müller, & Bernd Simon. (1989). Rioprostil in the Acute and Long-Term Treatment of Peptic Ulcers: A Review. Scandinavian Journal of Gastroenterology. 24(sup164). 207–213. 3 indexed citations
10.
Müller, Peter, et al.. (1989). Human gastric acid secretion following repeated doses of AG‐1749. Alimentary Pharmacology & Therapeutics. 3(2). 193–198. 40 indexed citations
11.
Dammann, H. G., M. Dreyer, R. Kangah, Peter Müller, & Bernd Simon. (1988). Optimale Reduktion der Magensäuresekretion bei peptischer Geschwürsbildung. Drugs. 35(Supplement 3). 106–113. 3 indexed citations
12.
Dammann, H. G., et al.. (1988). Clinical Characteristics of Roxatidine Acetate: A Review. Scandinavian Journal of Gastroenterology. 23(sup146). 121–134. 5 indexed citations
13.
Klotz, Ulrich, et al.. (1987). Nocturnal Doses of Ranitidine and Nizatidine Do not Affect the Disposition of Diazepam. The Journal of Clinical Pharmacology. 27(3). 210–212. 14 indexed citations
14.
Dammann, H. G., et al.. (1987). What are the current possibilities in treating peptic ulcer disease?. Alimentary Pharmacology & Therapeutics. 1(s1). 468S–492S. 5 indexed citations
15.
Simon, Bernd, Michel Cremer, H. G. Dammann, et al.. (1987). 300 Mg Nizatidine at Night versus 300 Mg Ranitidine at Night in Patients with Duodenal Ulcer: A Multicentre Trial in Europe. Scandinavian Journal of Gastroenterology. 22(sup136). 61–70. 22 indexed citations
16.
Dammann, H. G., et al.. (1987). The 24-Hour Acid Suppression Profile of Nizatidine. Scandinavian Journal of Gastroenterology. 22(sup136). 56–60. 11 indexed citations
17.
Martens, William B., et al.. (1986). 20 versus 30 mg Omeprazole Once Daily: Effect on Healing Rates in 115 Duodenal Ulcer Patients. Digestion. 33(2). 117–120. 16 indexed citations
18.
Dammann, H. G., et al.. (1986). Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer. The American Journal of Medicine. 81(2). 80–84. 32 indexed citations
19.
Müller, P, et al.. (1986). [Stomach tolerance of indomethacin derivatives: an endoscopic comparative study in healthy probands].. PubMed. 45(2). 68–70. 2 indexed citations
20.
Simon, Bradley T., et al.. (1981). Comparative effects of ICI 125,211 and cimetidine on antipyrine kinetics. British Journal of Clinical Pharmacology. 11(2). 214–215. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. J. Gavey Breakdown of academic impact, for papers by Lisa Suchower Breakdown of academic impact, for papers by Markus Goldschmiedt Breakdown of academic impact, for papers by T. Cilluffo Breakdown of academic impact, for papers by J. Zimmerman Breakdown of academic impact, for papers by L. Carling Breakdown of academic impact, for papers by V. Londong Breakdown of academic impact, for papers by Madeline H. Frame Breakdown of academic impact, for papers by I. G. M. Cleator Breakdown of academic impact, for papers by E Thornell
Rankless by CCL
2026